Andrew D. Goodman, M.D.

See information for Patients. Viewing information for Researchers.

Current Appointments

• Professor - Department of Neurology (SMD)

Education
MD Medicine	Coll of Medicine & Dentistry	1979
BA Arts & Sciences	Rutgers State University	1974

Post-Doctoral Training & Residency
Resident, Department of Neurology, Mount Sinai Medical Center, New York, NY	1980 - 1983
Resident, Department of Medicine, Mount Sinai Medical Center, New York, NY	1979 - 1980

Fellowship Awards
Medical Staff Fellow, Neuroimmunology Branch, NINCDS, National Institutes of Health, Bethesda, MD	1983 - 1988

Board Certifications
Board Certification: Amaerican Board of Psychiatry and Neurology	1986

Recent Journal Articles
Showing the 5 most recent journal articles. (56 available)
Goodman, AD; Rossman, H; Bar-Or, A; Miller, A; Miller, DH; Schmierer, K; Lublin, F; Khan, O; Bormann, NM; Yang, M; Panzara, MA; Sandrock, AW; GLANCE Investigators. "GLANCE: results of a phase 2, randomized, double-blind, placebo-controlled study." Neurology 3 (2009): 806-12..
Goodman AD; Brown TR; Drupp LB; Schapiro RT; Schwid SR; Cohen R; Marinucci LN; Blight AR; Fampridine MS-F203 Investigators. "Sustained-release oral fampridine in multiple sclerosis: a randomized double-blind, controlled trial." Lancet. 28 (2009): 697-8..
Mehta LR; Smauelsson MK; Kleiner AK; Goodman AD; Anolik JA; Loney JR and Schwid SR. "Neuromyelitis optica spectrum disorder in a patient with Ssstemic lupus erythematosus and anti-phospholipid antibody syndrome." Multiple Sclerosis 14 (2008): 425-427.
Mehta, LR and Goodman AD. "Disease Modifying Therapies." Continuum: Lifelong Learning in Neurology. 13 (2008): 144-80.
Goodman AD; Brown TR; Cohen JA; Krupp LB; Schapiro R; Schwid SR; Cohen R; Marinucci LN; Blight AR; . "Dose comparison trial of sustained-release fampridine in multiple sclerosis." Neurology. 2008; 71(15):1134-41. Epub 2008 Jul 30.